跳至主要内容
临床试验/TCTR20211110002
TCTR20211110002Enrolling By Invitation4 期

Effect of low-dose colchicine on arterial stiffness assessed by cardio-ankle vascular index in patients with diabetes mellitus

Faculty of Medicine, Prince of Songkhla University0 个研究点目标入组 60 人开始时间: 2021年11月10日最近更新:
适应症

试验速览

阶段
4 期
状态
Enrolling By Invitation
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
40 Years 至 60 Years(—)
性别
All

入选标准

  • 1. Type 2 diabetes melitus
  • 2. Met one of the following conditions: hyperlipidemia, hypertension, obesity defined as BMI greater than 25 kg/m2 or a waist circumference greater than 90 cm in males, or 80 cm in females

排除标准

  • 1. Diabetic patients using insulin or had significant proteinuria
  • 2. History of heart failure, or documented left ventricular ejection fraction less than 50%
  • 3. Coronary artery diseases
  • 4. History of myocardial infarction, ischemic stroke, peripheral arterial disease
  • 5. Recent smoking within 1 year prior to enrollment
  • 6. Hypertensive or diabetic medications were recent adjusted in previous 3 months prior to enrollment
  • 7. Atrial fibrillation
  • 8. Pateints with untreated, being treated malignancy, or evidence of tumor recurrence within 5 years
  • 9. History of inflammatory bowel disease
  • 10. Patients with chronic diarrhea
  • 11. History of neuromuscular disease
  • 12. Patients with cirrhosis or chronic hepatitis viral infection or severe liver dysfunction
  • 13. Elevated liver enzyme greater than 3 times of upper reference value
  • 14. Creainine clearance less than 50 ml/min
  • 15. Hemoglobin level less than 10 g/dL, or white blood cells less than 3,000 /mm3, or platelets less than 110,000 /mm3
  • 16. Patients with HIV infection
  • 17. History of colchicine use in previous 1 month before enrollment
  • 18. Patients with suspected fungal infection or being treated with angifungal drugs
  • 19. Female with planned or being pregnancy or breastfeeding within 1 year
  • 20. History of colchicine allergy
  • 21. Patients with ongoing or planned treatment with steroids
  • 22. Concurrent medications affecting to colchicine e.g. macrolides, antifungal medication (azole group, griseofulvin), verapamil, diltiazem, high dose simvastatin and atorvastatin
  • 23. Patients taking strong CYP3A4 inhibitors
  • 24. Elevated creatinine phosphokinase greater than 3 times of upper reference value
  • 25. Patients is participating other research program

研究者

发起方
Faculty of Medicine, Prince of Songkhla University

相似试验